RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000069.xml
PDF herunterladen
Semin Liver Dis 2013; 33(01): 062-070
DOI: 10.1055/s-0033-1338115
DOI: 10.1055/s-0033-1338115
Hepatitis E Virus Infection in Immunosuppressed Patients: Natural History and Therapy
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
05. April 2013 (online)
Abstract
Interest in hepatitis E virus (HEV) infection has increased over the last few years since chronic HEV infection was first reported in transplant patients. Chronic genotype-3 HEV infections have been now reported in patients with a solid-organ transplant, hematology disease, and in those who are human immunodeficiency virus-positive. Cases of HEV-related cirrhosis have been also reported. Furthermore, HEV associated extrahepatic manifestations, including neurologic symptoms, kidney injuries, and hematological disorders, have been reported. Antiviral therapies, such as pegylated-interferon and ribavirin, have been found to be efficient in treating HEV infection. The aim of this review is to summarize the incidence, natural history, risk factors, and treatment of HEV infections in immunosuppressed patients. HEV-induced extrahepatic manifestations are described.
-
References
- 1 Kamar N, Selves J, Mansuy JM , et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358 (8) 811-817
- 2 Kamar N, Bendall R, Legrand-Abravanel F , et al. Hepatitis E. Lancet 2012; 379 (9835) 2477-2488
- 3 Ollier L, Tieulie N, Sanderson F , et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150 (6) 430-431
- 4 Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361 (10) 1025-1027
- 5 Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012; 12 (9) 2281-2287
- 6 Drobeniuc J, Meng J, Reuter G , et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51 (3) e24-e27
- 7 Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82 (5) 799-805
- 8 Baylis SA, Hanschmann KM, Blümel J, Nübling CM. HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49 (4) 1234-1239
- 9 Legrand-Abravanel F, Kamar N, Sandres-Saune K , et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17 (1) 30-37
- 10 Legrand-Abravanel F, Lhomme S, Chapuy-Regaud S , et al. Hepatitis E virus reinfections in solid-organ-transplant patients recipients having anti-HEV antibodies. Submitted for publication
- 11 Pischke S, Suneetha PV, Baechlein C , et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16 (1) 74-82
- 12 Pischke S, Stiefel P, Franz B , et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant 2012; 12 (11) 3128-3133
- 13 Haagsma EB, Niesters HG, van den Berg AP , et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15 (10) 1225-1228
- 14 Pas SD, de Man RA, Mulders C , et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012; 18 (5) 869-872
- 15 Buti M, Cabrera C, Jardi R, Castells L, Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?. Liver Transpl 2010; 16 (1) 106-107 , author reply 108
- 16 Halac U, Béland K, Lapierre P , et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 61 (4) 597-603
- 17 Legrand-Abravanel F, Kamar N, Sandres-Saune K , et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202 (6) 835-844
- 18 Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. J Infect Dis 2005; 192 (5) 930-933
- 19 Mansuy JM, Legrand-Abravanel F, Calot JP , et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80 (2) 289-293
- 20 Mansuy JM, Bendall R, Legrand-Abravanel F , et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17 (12) 2309-2312
- 21 Schlosser B, Stein A, Neuhaus R , et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56 (2) 500-502
- 22 Tamura A, Shimizu YK, Tanaka T , et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37 (2) 113-120
- 23 Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004; 19 (7) 778-784
- 24 Mitsui T, Tsukamoto Y, Yamazaki C , et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004; 74 (4) 563-572
- 25 Ayoola EA, Want MA, Gadour MO, Al-Hazmi MH, Hamza MK. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol 2002; 66 (3) 329-334
- 26 Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009; 48 (3) 373-374
- 27 Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358 (8) 859-860
- 28 Kamar N, Mansuy JM, Cointault O , et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8 (8) 1744-1748
- 29 Haagsma EB, van den Berg AP, Porte RJ , et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14 (4) 547-553
- 30 Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50 (3) 622-624
- 31 Kamar N, Abravanel F, Selves J , et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89 (3) 353-360
- 32 Mallet V, Nicand E, Sultanik P , et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153 (2) 85-89
- 33 Vantyghem MC, Mathurin P, Hober D , et al. Partial graft recovery following eradication of hepatitis E virus infection after successful islet allograft transplantation. Transpl Int 2011; 24 (1) e13-e15
- 34 Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30 (7) 841-843
- 35 Halleux D, Kanaan N, Kabamba B, Thomas I, Hassoun Z. Hepatitis E virus: an underdiagnosed cause of chronic hepatitis in renal transplant recipients. Transpl Infect Dis 2012; 14 (1) 99-102
- 36 de Niet A, Zaaijer HL, ten Berge I, Weegink CJ, Reesink HW, Beuers U. Chronic hepatitis E after solid organ transplantation. Neth J Med 2012; 70 (6) 261-266
- 37 Motte A, Roquelaure B, Galambrun C, Bernard F, Zandotti C, Colson P. Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol 2012; 53 (2) 162-166
- 38 Kamar N, Garrouste C, Haagsma EB , et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140 (5) 1481-1489
- 39 Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8 (11) 698-709
- 40 Lhomme S, Abravanel F, Dubois M , et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86 (18) 10006-10014
- 41 Suneetha PV, Pischke S, Schlaphoff V , et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55 (3) 695-708
- 42 Kamar N, Legrand-Abravanel F, Dalton HR, Izopet J. Hepatitis E virus-specific T-cell response after transplantation. Hepatology 2012; 55 (5) 1643 , author reply 1644
- 43 Kamar N, Rostaing L, Abravanel F , et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50 (5) e30-e33
- 44 Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16 (4) 474-477
- 45 Dong C, Zafrullah M, Mixson-Hayden T , et al. Suppression of interferon-α signaling by hepatitis E virus. Hepatology 2012; 55 (5) 1324-1332
- 46 Kamar N, Rostaing L, Abravanel F , et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139 (5) 1612-1618
- 47 Bruchfeld A, Lindahl K, Schvarcz R, Ståhle L. Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 2002; 24 (6) 701-708
- 48 Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. Am J Kidney Dis 2004; 43 (1) 140-146
- 49 Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59 (10) 1426-1431
- 50 Péron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?. J Hepatol 2011; 54 (6) 1323-1324 , author reply 1324–1325
- 51 Kamar N, Abravanel F, Garrouste C , et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010; 25 (8) 2792-2795
- 52 Kamar N, Izopet J, Rostaing L. No reactivation of hepatitis e virus after kidney retransplantation. Am J Transplant 2012; 12 (2) 507-508
- 53 Péron JM, Mansuy JM, Récher C , et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006; 21 (7) 1223-1224
- 54 Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010; 153 (2) 135-136
- 55 Tavitian S, Péron JM, Huynh A , et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010; 49 (2) 141-144
- 56 Koenecke C, Pischke S, Heim A , et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?. Transpl Infect Dis 2012; 14 (1) 103-106
- 57 Abravanel F, Mansuy JM, Huynh A , et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012; 54 (2) 152-155
- 58 Halac U, Béland K, Lapierre P , et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012; 160 (5) 871-4 , e1
- 59 le Coutre P, Meisel H, Hofmann J , et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58 (5) 699-702
- 60 Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011; 106 (8) 1562-1563
- 61 Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P , et al; Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17 (6) 1074-1078
- 62 Renou C, Lafeuillade A, Cadranel JF , et al; ANGH. Hepatitis E virus in HIV-infected patients. AIDS 2010; 24 (10) 1493-1499
- 63 Sellier P, Mazeron MC, Tesse S , et al. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J 2011; 8: 171
- 64 Maylin S, Stephan R, Molina JM , et al. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. J Clin Virol 2012; 53 (4) 346-349
- 65 Kaba M, Richet H, Ravaux I , et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011; 83 (10) 1704-1716
- 66 van Welzen BJ, Verduyn Lunel FM, Meindertsma F, Hoepelman AI, Arends JE. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. J Acquir Immune Defic Syndr 2012; 60 (2) e65-e67
- 67 Pischke S, Ho H, Urbanek F , et al. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 2010; 17 (8) 598-599
- 68 Crum-Cianflone NF, Curry J, Drobeniuc J , et al; Infectious Disease Clinical Research Program HIV Working Group. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012; 18 (3) 502-506
- 69 Jardi R, Crespo M, Homs M , et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012; 13 (6) 379-383
- 70 Keane F, Gompels M, Bendall R , et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012; 13 (1) 83-88
- 71 Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009; 16 (12) 895-896
- 72 Colson P, Dhiver C, Gérolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 2008; 14 (12) 1176-1180
- 73 Thoden J, Venhoff N, Miehle N , et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008; 22 (7) 909-910
- 74 Curry JA, Adams N, Crum-Cianflone NF. Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med 2009; 150 (3) 226-227
- 75 Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009; 45 (4) 269-271
- 76 Colson P, Gérolami R, Moreau J, Borentain P, Brouqui P. Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: one virus may hide another. Int J Infect Dis 2010; 14 (4) e357
- 77 Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gérolami R. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 2011; 18 (3) 227-228
- 78 Shukla P, Nguyen HT, Torian U , et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011; 108 (6) 2438-2443
- 79 Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011; 155 (7) 479-480
- 80 Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol 2000; 95 (12) 3667-3668
- 81 Kamani P, Baijal R, Amarapurkar D , et al. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol 2005; 24 (5) 216
- 82 Loly JP, Rikir E, Seivert M , et al. Guillain-Barré syndrome following hepatitis E. World J Gastroenterol 2009; 15 (13) 1645-1647
- 83 Chalupa P, Holub M. Jaundice complicated by an atypical form of Guillain-Barré syndrome. J Clin Virol 2010; 49 (4) 229-230
- 84 Despierres LA, Kaphan E, Attarian S , et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis 2011; 17 (8) 1510-1512
- 85 Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 2012; 40 (3) 323-326
- 86 Cronin S, McNicholas R, Kavanagh E, Reid V, O'Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci 2011; 180 (1) 255-257
- 87 Tse AC, Cheung RT, Ho SL, Chan KH. Guillain-Barré syndrome associated with acute hepatitis E infection. J Clin Neurosci 2012; 19 (4) 607-608
- 88 Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell's palsy. J Assoc Physicians India 2006; 54: 418
- 89 Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009; 111 (2) 193-195
- 90 Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis 2010; 42 (5) 395-400
- 91 Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 2006; 43 (4) 365-366
- 92 Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001; 57 (10) 1935
- 93 Kamar N, Bendall RP, Peron JM , et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17 (2) 173-179
- 94 Kamar N, Izopet J, Cintas P , et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010; 10 (5) 1321-1324
- 95 Del Bello A, Arné-Bes MC, Lavayssière L, Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol 2012; 57 (5) 1152-1153
- 96 Kamar N, Mansuy JM, Esposito L , et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis 2005; 45 (1) 193-196
- 97 Kamar N, Weclawiak H, Guilbeau-Frugier C , et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93 (6) 617-623
- 98 Sinha S, Jha R, Lakhtakia S, Narayan G. Acute pancreatitis following kidney transplantation - role of viral infections. Clin Transplant 2003; 17 (1) 32-36
- 99 Bhagat S, Wadhawan M, Sud R, Arora A. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas 2008; 36 (4) 424-427
- 100 Thapa R, Biswas B, Mallick D, Ghosh A. Acute pancreatitis—complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin Pediatr (Phila) 2009; 48 (2) 199-201
- 101 Deniel C, Coton T, Brardjanian S, Guisset M, Nicand E, Simon F. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol 2011; 51 (3) 202-204
- 102 Colson P, Payraudeau E, Leonnet C , et al. Severe thrombocytopenia associated with acute hepatitis E virus infection. J Clin Microbiol 2008; 46 (7) 2450-2452
- 103 Fourquet E, Mansuy JM, Bureau C , et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48 (1) 73-74
- 104 Shah SA, Lal A, Idrees M , et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol 2012; 54 (1) 96-97